 |
|
End-stage renal disease incidence, prognosis improving for patients with diabetes
October 12, 2005Patients with type 1 diabetes have an improved prognosis with regard to end-stage renal disease over the past four decades, and it appears the incidence of end-stage renal disease is lower than previously estimated, according to a study in the October 12 issue of JAMA.
Diabetic kidney disease is one of the most severe complications of type 1 diabetes, and diabetes is the most important cause of end-stage renal disease (ESRD; severely impaired kidney function, requiring dialysis) in industrialized countries, according to background information in the article. Data on patients' risk of developing ESRD are sparse. Large population-based studies with long-term follow-up have not been performed; therefore, the true incidence and age- and sex-stratified risk estimates of ESRD among patients with type 1 diabetes are not known.
Patrik Finne, M.D., Ph.D., of Helsinki University, Finland, and colleagues estimated the long-term risk of ESRD and death in patients with type 1 diabetes and assessed how age at diagnosis of diabetes, time period of diagnosis, and sex affect these risks. The study included patients younger than 30 years at the time of being diagnosed with type 1 diabetes in Finland in 1965-1999 (n = 20,005), who were identified from the Finnish Diabetes Register. The group was followed from diagnosis of diabetes until development of ESRD (dialysis or kidney transplantation as identified from the Finnish Registry for Kidney Diseases), death, or end of follow-up on December 31, 2001.
The median follow-up time after diagnosis was 16.7 years, with a maximum of 37 years. During the follow-up period, there were 632 cases of ESRD and 1,417 deaths. The researchers found that the cumulative incidence among all type 1 diabetic patients was 2.2 percent at 20 years and 7.8 percent at 30 years after diagnosis. Patients of both sexes diagnosed as having type 1 diabetes before age 5 years had a smaller risk of developing ESRD (3.3 percent after 30 years) than other patients (8.4 percent). The risk of ESRD was lower for patients diagnosed as having type 1 diabetes in later years. The risk did not differ significantly between sexes.
Patients with ESRD had 13.1 times the risk of death compared with other patients with type 1 diabetes when adjusting for age, sex, and time period of diabetes diagnosis. "This emphasizes the severity of ESRD as a complication of diabetes," the authors write. The cumulative death rate was 6.8 percent at 20 years and 15.0 percent at 30 years after diagnosis of type 1 diabetes. The cumulative risk of dying with ESRD was 0.7 percent at 20 years and 3.3 percent at 30 years after diagnosis of type 1 diabetes. The risk of death increased with age at diagnosis. The time period for the diagnosis of diabetes strongly affected survival: patients with diagnosis in 1975-1979 had 48 percent lower risk of dying than those with diagnosis in 1965-1969.
"In conclusion, our data indicate improved prognosis of type 1 diabetes with regard to both ESRD and death," the researchers write. "The overall incidence of ESRD appears to be lower than previously reported."
JAMA and Archives Journals
The median follow-up time after diagnosis was 16.7 years, with a maximum of 37 years. During the follow-up period, there were 632 cases of ESRD and 1,417 deaths. The researchers found that the cumulative incidence among all type 1 diabetic patients was 2.2 percent at 20 years and 7.8 percent at 30 years after diagnosis. Patients of both sexes diagnosed as having type 1 diabetes before age 5 years had a smaller risk of developing ESRD (3.3 percent after 30 years) than other patients (8.4 percent). The risk of ESRD was lower for patients diagnosed as having type 1 diabetes in later years. The risk did not differ significantly between sexes.
Patients with ESRD had 13.1 times the risk of death compared with other patients with type 1 diabetes when adjusting for age, sex, and time period of diabetes diagnosis. "This emphasizes the severity of ESRD as a complication of diabetes," the authors write. The cumulative death rate was 6.8 percent at 20 years and 15.0 percent at 30 years after diagnosis of type 1 diabetes. The cumulative risk of dying with ESRD was 0.7 percent at 20 years and 3.3 percent at 30 years after diagnosis of type 1 diabetes. The risk of death increased with age at diagnosis. The time period for the diagnosis of diabetes strongly affected survival: patients with diagnosis in 1975-1979 had 48 percent lower risk of dying than those with diagnosis in 1965-1969.
"In conclusion, our data indicate improved prognosis of type 1 diabetes with regard to both ESRD and death," the researchers write. "The overall incidence of ESRD appears to be lower than previously reported."
JAMA and Archives Journals
Type 1 Diabetes Current Events and Type 1 Diabetes News RSSUM Scientists Create Fruit Fly Model to Help Unravel Genetics of Human Diabetes
As rates of obesity, diabetes, and related disorders have reached epidemic proportions in the US in recent years, scientists are working from many angles to pinpoint the causes and contributing factors involved in this public health crisis.
Vegetables can protect unborn child against diabetes
New evidence is emerging for how important it is for pregnant women to eat good, nutritious food. Expecting mothers who eat vegetables every day seem to have children who are less likely to develop type 1 diabetes, a new study from the Sahlgrenska Academy has revealed.
Protein critical for insulin secretion may be contributor to diabetes
A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes.
Diabetic Episodes Affect Kids' Memory
Children who have had an episode of diabetic ketoacidosis, a common complication of diabetes, may have persistent memory problems, according to a new study from researchers at the UC Davis Center for Mind and Brain.
A major step in making better stem cells from adult tissue
October 15, 2009 A team led by scientists from The Scripps Research Institute has developed a method that dramatically improves the efficiency of creating stem cells from human adult tissue, without the use of embryonic cells.
Blood counts are clues to human disease
A new genome-wide association study published today in Nature Genetics begins to uncover the basis of genetic variations in eight blood measurements and the impact those variants can have on common human diseases.
Self-monitoring of blood glucose
Diabetes patients should always control their own blood sugar values if this leads to improvements in their treatment.
Is inhaled insulin delivery still a possibility? Why has it been a commercial failure?
The commercial failure of Exubera® (Pfizer, New York, NY), the first inhaled insulin product to come to market, led other companies such as Eli Lilly-Alkermes to halt studies of similar drug delivery in development intended to compete for a share of the lucrative diabetes market.
Visionary concept earns La Jolla Institute scientist prestigious NIH Pioneer Award
A scientist at the La Jolla Institute for Allergy & Immunology has received one of the National Institutes of Health (NIH)'s top awards -- the 2009 NIH Director's Pioneer Award.
JDRF-funded studies show regular CGM use increases diabetes control for all age groups
The latest data from groundbreaking human clinical trials of the effectiveness of continuous glucose monitors (CGM) show that the primary determinant of improvements in achieving better diabetes control is regular use of monitors - six days per week or more - rather than the age of patients, and that benefits continue well past the time when people with type 1 diabetes begin using the devices - including experiencing fewer low blood sugar emergencies.
More Type 1 Diabetes Current Events and Type 1 Diabetes News Articles
 |
Type 1 Diabetes For Dummies (For Dummies (Health & Fitness)) by Alan L. Rubin MD (Author) Whether you have been living with type 1 diabetes for some time, or you have just discovered that your child is diabetic, there’s a lot you need to know about the new developments in treating, controlling, and living with this disease. Type 1 Diabetes For Dummies, explains everything you need to know and do to make living with type 1 diabetes easier and healthier. This reassuring, plain-English guide helps you understand and mange the disease with tips on working with your doctor, administering insulin, developing a diet an exercise plan, and coping with illness and travel. You’ll find out about the latest technologies of blood glucose monitoring and insulin delivery, and get a handle on everything you need to do to keep yourself or your child healthy, active, and feeling... |
 |
Type 1 Diabetes: A Guide for Children, Adolescents, Young Adults--and Their Caregivers, Third Edition by M.D. Ragnar Hanas M.D. (Author), Ph.D. Stuart Brink Ph.D. (Foreword), Jeff Hitchcock (Foreword) Living with type 1 diabetes requires intensive, nonstop daily management, week after week, year after year. This means that young people with type 1 and their parents have to become experts on their own condition—even better informed than the average doctor—and able to self-manage its daily demands. The Type 1 Diabetes Book is the most authoritative book ever published on the condition and will become the one book that every young person with type 1 diabetes will need to own. "In this book," writes author Dr. Ragnar Hanas, "I speak directly, all the time, to you, the person with diabetes. The topics covered range from how your body works to sweets, treats, and ice cream; from insulin injection technique to long-term complications; and any number of subjects in between. With this book... |
 |
Medical Management of Type 1 Diabetes by American Diabetes Association (ADA) (Author) Featuring a recommended course of diagnosing and treating patients with type 1 diabetes A comprehensive resource for health care professionals that outlines the American Diabetes Association’s recommended course of diagnosing and treating patients with type 1 diabetes. This comprehensive volume provides the basis for individualized, flexible, responsive treatment plans for patients with type 1 diabetes. It includes integrated approaches on blood pressure and lipid goals, proper nutrition, exercise, smoking cessation, and more. All based on the clinical practice recommendations of the American Diabetes Association. |
 |
A Field Guide to Type 1 Diabetes by American Diabetes Association (Author) Living with diabetes is as challenging as hiking and camping in the wilderness. As it always pays to be prepared before beginning a journey, it also pays for people with diabetes to be prepared before they start each day. In true Field Guide fashion, this book boils down vital information for readers into short sections and checklists of their necessities, what they need to do, and what to take with them on the course of their day. A Field Guide to Type 1 Diabetes includes sections on insulin; tools, food, and exercise; complications; and how to's. Key features include: Background on the biology and physical aspects of type 1 diabetes Vital information about insulin, insulin plans, and delivery methods Easy-to-understand charts and checklists that walk readers through... |
 |
Insulin Pump Therapy Demystified: An Essential Guide for Everyone Pumping Insulin (Marlowe Diabetes Library) by Gabrielle Kaplan-Mayer (Author), M.S. Gary Scheiner M.S. (Foreword) Increasing numbers of people with type 1 diabetes, all of whose lives depend on insulin, as well as type 2 diabetics, have already adopted the insulin pump, which replaces a regimen of insulin shots with a continuous delivery of insulin. Yet many who stand to benefit from "the pump" are put off by not fully understanding the device, and many already using it don’t have anyone with whom to compare notes about its use. Now Gabrielle Kaplan-Mayer, who has used the pump for more than three years, cuts through common personal fears about the pump and offers insight into the day-to-day challenges—and rewards—of life with it. Drawing on interviews with more than seventy-five pump users, including Nicole Johnson, Miss America 1999, as well as diabetes experts and other health professionals,... |
 |
Think Like a Pancreas: A Practical Guide to Managing Diabetes with Insulin by M.S. Gary Scheiner M.S. (Author), Ph.D. Barry Goldstein M.D. M.D. (Foreword) Dozens of books offer advice on managing diabetes, but few focus specifically on the day-to-day issues facing those who use insulin. Now Gary Scheiner, a certified diabetes educator and himself an insulin user himself since 1985, gives you the tools to "think like a pancreas"--that is, to successfully master the art and science of matching insulin to the body’s ever-changing needs. Free of medical mumbo jumbo, comprehensive, and packed with useful information not readily available in other books, Think Like a Pancreas discusses: • day-to-day blood glucose control and monitoring |
 |
WeeklyTrack Diabetes Management Kit (The Complete Diabetes Self-Management Log Book) by OSS Publishing Company (Author) Improve your diabetes self-management! This easy-to-use diabetes log book covers all aspects of diabetes self-care for Type 1 or Type 2 diabetics, whether using oral medications (pills), insulin injections, or an insulin pump. No more chasing separate pieces of paper and fumbling with tiny booklets!WeeklyTrack Diabetes Management Kit keeps all of your detailed diabetes information in one book, but still shows you the "big picture" of your diabetes management. Each WeeklyTrack book holds one full year of information. Unlike other systems, there are no refills or extras to buy. One book per year is all you need. It's not a calendar -- start when you want, fill in your own dates. Designed by a diabetic, WeeklyTrack provides daily diabetes logging with color-coded charts in a unique... |
 |
Practical Management Of Type 1 Diabetes by Irl B. Hirsch (Author), Steven V. Edelman (Author) Relevant pathophysiology and pathogenesis are reviewed. Glycemic goals and a detailed review of the various insulin preparations, delivery systems, and appropriate treatment regimens are presented. Synthetic amylin analogs are also discussed. Guidance on the management of acute and long-term complications is provided. |
 |
Appraise Hemoglobin A1C Home Test Kit by Appraise INDICATIONS: Appraise diabetes A1c home test kit, 90462. Clinically accurate information you can use with your Healthcare provider to assess your daibetes treatment plan. |
 |
No Added Sugar - growing up with type 1 diabetes by Fibi Ward (Author) Fibi Ward, now 14, writes: 'At the time I was diagnosed [aged 13], I wanted to read something written by somebody of my own age, from their perspective, about how they dealt with being diagnosed, and to reassure myself that all the fears and worries that I had were normal. However,I have not seen any such book on the market and have decided to record my own experiences so that other children and teenagers who are newly diagnosed with type 1 diabetes can get some benefit and comfort by reading about and relating to them.' According to Diabetes UK, 10,000 to 15,000 people in the UK are diagnosed with type 1 diabetes every year. The peak age of diagnosis is between 10 and 14 years. Coming so early in life, such a diagnosis can feel like a life sentence, both for the young person and for... |
| © 2009 BrightSurf.com |